Mao Renling
Professor
Director of Neurosurgery and Director of the First Ward, Shanghai Yida Hospital
Corresponding author of China's first "Clinical Guidelines for the Diagnosis and Treatment of Idiopathic Normal Pressure Hydrocephalus"
Mao Renling, Chief Physician and Professor, graduated from Shanghai Medical University and has worked in clinical care, teaching and research in neurosurgery for more than 40 years. He worked in neurosurgery at Conde S. Januário General Hospital in Macau, and studied and worked for more than 30 years at Huashan Hospital affiliated to Fudan University; he now serves as Director of Neurosurgery at Huadong Hospital affiliated to Fudan University and Director of Neurosurgery and Director of the First Ward at Yida Hospital, School of Medicine, Shanghai University.
As a recruited talent of Huadong Hospital, he has served as head and discipline leader of neurosurgery for nearly 10 years, driving the coordinated development of neurology, medical imaging, pathology, radiotherapy, anesthesiology and other disciplines. He has long been dedicated to the diagnosis and treatment of neuro-oncology, stroke, traumatic brain injury and geriatric neurosurgical conditions, with extensive clinical experience in areas such as minimally invasive treatment of trigeminal neuralgia in the elderly, minimally invasive surgery for skull base tumors, treatment of chronic subdural hematoma and idiopathic normal pressure hydrocephalus.
He specializes in the diagnosis and surgical treatment of common and difficult neurosurgical conditions such as neuro-oncology, stroke and traumatic brain injury, and skillfully performs neurosurgical procedures such as minimally invasive treatment of trigeminal neuralgia in the elderly, minimally invasive surgery for skull base tumors and treatment of chronic subdural hematoma.
He has long focused on the clinical diagnosis, treatment and research of idiopathic normal pressure hydrocephalus, and is one of the leading experts in this field in China, with extensive experience in standardized diagnosis, precise treatment and perioperative management of the condition.
He has long conducted clinical and basic research into idiopathic normal pressure hydrocephalus and geriatric neurosurgical conditions, and is the corresponding author of China's first "Clinical Guidelines for the Diagnosis and Treatment of Idiopathic Normal Pressure Hydrocephalus"; the related research achievements received the First Prize of the Shanghai Rehabilitation Medicine Science and Technology Award and are at a leading level in China.
He has led 2 municipal research projects and taken part in more than 20 research projects at national, municipal and bureau level, including the National Natural Science Foundation; he has published more than 20 SCI papers as first or corresponding author and taken part in writing 10 academic monographs. His research achievements have received a number of awards, including the Third Prize of the Ministry of Health Science and Technology Progress Award, the Third Prize of the Shanghai Science and Technology Progress Award (twice) and the Third Prize of the Shanghai Health Bureau Medical Science and Technology Progress Award.
5 nationally granted patents
Standing Committee Member, Neurodegenerative Disease Committee, Chinese Society of Microcirculation
Deputy Chairman, Hydrocephalus Group, Neurodegenerative Disease Committee, Chinese Society of Microcirculation
Member of the Glioma Committee and member of the Geriatric Glioma Group, Chinese Medical Doctor Association
Head, Advanced Research Center, China Hydrocephalus Alliance
Member of the Neurosurgery Branch and member of the Neuro-oncology Group, Shanghai Medical Association
Member, Neurosurgeons Branch, Shanghai Medical Doctor Association
Member, Shanghai Medical Malpractice Technical Appraisal Expert Pool
Member, Shanghai Adverse Vaccination Reaction Appraisal Expert Pool
